Medtronic plc logo
Medtronic plc (MDT)
Compare

Medtronic plc (MDT) Quick Ratio (Acid-Test): 0.00

Is Medtronic plc’s quick ratio (acid-test) high or low?

Medtronic plc's quick ratio (acid-test) of 0.00 is 100% below its 4-year average of 1.68, near the low end of its 4-year range (0.00–2.14).

As of Thursday, June 11, 2026. 100.00% below its 12-month average of 1.48.

MDT Quick Ratio (Acid-Test) Chart

MDT Quick Ratio (Acid-Test)
1.42-8.39% 1Y
Zoom

MDT Average Quick Ratio (Acid-Test) Chart

MDT Current vs Average Quick Ratio (Acid-Test) Chart

MDT Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

0.00

QUICK RATIO (ACID-TEST) AVG TTM

1.48

QUICK RATIO (ACID-TEST) AVG 3Y

1.57

QUICK RATIO (ACID-TEST) AVG 5Y

1.68

QUICK RATIO (ACID-TEST) AVG 10Y

1.95

QUICK RATIO (ACID-TEST) AVG 15Y

2.10

QUICK RATIO (ACID-TEST) AVG 20Y

2.09

CURRENT VS TTM AVG

-100.00%

CURRENT VS 3Y AVG

-100.00%

CURRENT VS 5Y AVG

-100.00%

CURRENT VS 10Y AVG

-100.00%

CURRENT VS 15Y AVG

-100.00%

CURRENT VS 20Y AVG

-100.00%

MDT Competitors' Quick Ratio (Acid-Test)

NAMEMARKET CAPQUICK RATIO (ACID-TEST)TTM3Y5Y
Medtronic plc (MDT)$102.72B0.001.481.571.68
Vertex Pharmaceuticals Incorporated (VRTX)$112.95B2.462.413.313.62
Bristol-Myers Squibb Company (BMY)$116.19B1.141.151.191.27
Elevance Health Inc. (ELV)$86.69B1.241.171.081.07
Danaher Corporation (DHR)$126.39B1.511.281.371.36
CVS Health Corporation (CVS)$126.70B0.630.610.630.63
Cigna Corporation (CI)$77.92B0.720.720.680.69
Regeneron Pharmaceuticals, Inc. (REGN)$63.00B3.393.674.143.76
Intuitive Surgical, Inc. (ISRG)$146.23B3.963.593.744.30
Pfizer Inc. (PFE)$149.18B0.870.900.870.95

Liquidity Comparison

Quick Ratio

0.00

Excludes inventory

Current Ratio

0.00

Includes inventory

Medtronic plc Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio = (Current Assets − Inventory) / Current Liabilities

The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Medtronic plc Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Medtronic plc (MDT)?
The quick ratio (acid-test) for MDT stock is 0.00.
Is Medtronic plc's quick ratio (acid-test) high or low?
Medtronic plc's quick ratio (acid-test) of 0.00 is 100% below its 4-year average of 1.68, near the low end of its 4-year range (0.00–2.14).
What is the TTM average quick ratio (acid-test) for Medtronic plc (MDT)?
The TTM average quick ratio (acid-test) for MDT stock is 1.48.
What is the 3Y average quick ratio (acid-test) for Medtronic plc (MDT)?
The 3Y average quick ratio (acid-test) for MDT stock is 1.57.
What is the 5Y average quick ratio (acid-test) for Medtronic plc (MDT)?
The 5Y average quick ratio (acid-test) for MDT stock is 1.68.
What is the 10Y average quick ratio (acid-test) for Medtronic plc (MDT)?
The 10Y average quick ratio (acid-test) for MDT stock is 1.95.
What is the 15Y average quick ratio (acid-test) for Medtronic plc (MDT)?
The 15Y average quick ratio (acid-test) for MDT stock is 2.10.
What is the 20Y average quick ratio (acid-test) for Medtronic plc (MDT)?
The 20Y average quick ratio (acid-test) for MDT stock is 2.09.

Medtronic plc Quick Ratio (Acid-Test) History

DATEQUICK RATIO (ACID-TEST)
2025-04-251.42
2024-04-261.55
2023-04-281.81
2022-04-291.49
2021-04-302.14
2020-04-241.72
2019-04-302.15
2018-04-301.92
2017-04-301.51
2016-04-302.81
2015-04-302.98
2014-04-303.50
2013-04-304.06
2012-04-301.37
2011-04-301.57
2010-04-301.63
2009-04-301.92
2008-04-301.71
2007-04-302.62
2006-04-302.09
2005-04-301.91
2004-04-301.05
2003-04-301.93
2002-04-300.69
2001-04-302.23
2000-04-302.34
1999-04-301.86
1998-04-302.13
1997-04-301.84

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway
95,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha